You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 7, July 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Sarcoidosis
 •Alert me on articles by topic

VIGNETTES
Recalcitrant Cutaneous Sarcoidosis Responding to Infliximab

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sarcoidosis is a multisystem disease, manifesting with cutaneous involvement in approximately 25% of patients.1 Lesions present in a wide variety of forms, including lupus pernio, violaceous papules and plaques, subcutaneous nodules, alopecia, ichthyosis, or verrucous growths. We describe a woman with cutaneous sarcoidosis refractory to treatment with multiple systemic agents who improved dramatically with infliximab therapy.

Report of a Case

A 51-year-old white woman presented with a painful itchy rash of 1 year’s duration (Figure 1). Her medical history was significant for an extensive hot-water burn 13 years prior that required skin grafting. Review of systems was significant for dull muscle aches.


 
Figure appears in full text version.
Figure 1. Clinical involvement before infliximab therapy.


Cutaneous examination revealed multiple violaceous papules and plaques. Histologic analysis of punch biopsy specimens revealed multiple dermal noncaseating granulomas, confirming a diagnosis of sarcoidosis. Standard laboratory findings from a complete blood cell count and liver and renal function testing were normal. The angiotension-converting . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION
Michael P. Heffernan, MD; Milan J. Anadkat, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.